KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 133 filers reported holding KARUNA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 3.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,213,352 | -47.3% | 137,284 | -32.4% | 0.02% | -45.5% |
| Q2 2023 | $44,026,188 | +46.4% | 203,026 | +22.7% | 0.04% | +37.5% |
| Q1 2023 | $30,064,871 | -50.4% | 165,519 | -46.4% | 0.03% | -52.2% |
| Q4 2022 | $60,655,621 | -17.8% | 308,680 | -5.9% | 0.07% | -23.9% |
| Q3 2022 | $73,804,000 | +10580.8% | 328,120 | +5909.5% | 0.09% | +8700.0% |
| Q2 2022 | $691,000 | -65.3% | 5,460 | -66.5% | 0.00% | -50.0% |
| Q3 2021 | $1,992,000 | +1.3% | 16,285 | -5.6% | 0.00% | 0.0% |
| Q2 2021 | $1,966,000 | +144.5% | 17,249 | +139.2% | 0.00% | +100.0% |
| Q2 2020 | $804,000 | -60.6% | 7,211 | -73.4% | 0.00% | -50.0% |
| Q4 2019 | $2,043,000 | – | 27,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |